OMNI BIO PHARMACEUTICAL, INC. 4
4 · OMNI BIO PHARMACEUTICAL, INC. · Filed Apr 9, 2015
Insider Transaction Report
Form 4
BOCO Investments LLC
10% Owner
Transactions
- Purchase
Common
2015-02-27$0.25/sh+2,998,678$749,670→ 10,132,678 total - Purchase
Warrant
2014-04-18+3,000,000→ 10,350,000 totalExercise: $0.01From: 2014-04-18Exp: 2015-04-15→ Common Stock (3,000,000 underlying) - Exercise of In-Money
Warrant
2015-02-27$0.01/sh−3,000,000$30,000→ 4,950,000 totalExercise: $0.01From: 2014-04-18Exp: 2015-04-15→ Common Stock (3,000,000 underlying) - Conversion
Convertible Note
2015-02-27$0.25/sh−2,400,000$600,000→ 7,950,000 totalExercise: $0.25From: 2012-10-31Exp: 2015-10-31→ Common Stock (2,998,678 underlying) - Other
Warrant
2014-04-18+2,900,000→ 7,350,000 totalExercise: $0.25From: 2009-03-31Exp: 2019-12-31→ Common Stock (2,900,000 underlying) - Other
Warrant
2014-04-18−1,450,000→ 7,350,000 totalExercise: $0.25From: 2009-03-31Exp: 2017-03-31→ Common Stock (1,450,000 underlying) - Other
Warrant
2014-04-18+1,450,000→ 7,350,000 totalExercise: $0.25From: 2009-03-31Exp: 2019-12-31→ Common Stock (1,450,000 underlying) - Purchase
Common
2015-02-27$0.01/sh+3,000,000$30,000→ 13,132,678 total - Other
Warrant
2014-04-18−2,900,000→ 7,350,000 totalExercise: $0.25From: 2009-03-31Exp: 2017-03-31→ Common Stock (2,900,000 underlying)
Footnotes (3)
- [F1]This Warrant amends and restates in its entirety a previous Warrant for the same number of shares for the purpose extending the contractual period to December 31, 2019 and resetting of the Exercise Price to $0.25.
- [F2]Conversion of the previously reported $600,000 Convertible Promissory Note with principal of $600,000 and accrued interest of $149,669.58.
- [F3]Exercise of the previously reported 3,000,000 warrants.